Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Dec;130(3):379-85.
doi: 10.1046/j.1365-2249.2002.02013.x.

Induction of IL-15 by TCR/CD3 aggregation depends on IFN-gamma and protects against apoptosis of immature thymocytes in vivo

Affiliations

Induction of IL-15 by TCR/CD3 aggregation depends on IFN-gamma and protects against apoptosis of immature thymocytes in vivo

P Matthys et al. Clin Exp Immunol. 2002 Dec.

Abstract

TCR/CD3 aggregation by injection of anti-CD3 Ab produces T cell activation, release of cytokines such as IFN-gamma, and apoptosis in the cortical region of the thymus. We show that anti-CD3 Ab induces IL-15 mRNA in spleens of wild-type but not IFN-gamma receptor-knock-out (IFN-gammaR KO) mice. The loss of IL-15 mRNA induction in IFN-gammaR KO mice was associated with increased thymocyte apoptosis. Pretreatment of wild-type mice with neutralizing anti-IL-15 Ab increased the anti-CD3-triggered thymocyte apoptosis, thus mimicking the sensitive phenotype of IFN-gammaR KO mice. Inversely, anti-CD3-induced apoptosis in IFN-gammaR KO mice was suppressed by administration of recombinant IL-15. In IFN-gammaR KO mice and in wild-type mice that were treated with anti-IL-15, augmented apoptosis affected mainly CD4+CD8+ immature thymocytes. IL-15 as well as IL-15Ralpha mRNA expression in thymocytes was not increased by anti-CD3. These data demonstrate that systemic IL-15 exerts anti-apoptotic activity on immature T cells and establish a regulatory mechanism whereby TCR/CD3 engagement induces IL-15 expression via an IFN-gamma-dependent pathway. The self-amplifying nature of this IFN-gamma/IL-15 connection may constitute a regulatory pathway in central tolerance to self.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Anti-CD3 Ab induces severe apoptosis in thymuses of IFN-γR KO mice. Groups of 3 IFN-γR KO and 3 wild-type mice were challenged with 0, 20 or 40 µg anti-CD3 Ab. Forty hours post anti-CD3 challenge, thymocytes were analysed by flow cytometry for (a) their DNA content and (b) their staining pattern for CD4 and CD8. (a) PI fluorescence intensity: a representative histogram from one mouse out of three is shown. Value represents the percentage of apoptotic cells. (b) Thymocyte subpopulations in IFN-γR KO and wild-type mice. Each plot represents analysis of one mouse. The absolute number of each subpopulation as well as the total number of thymocytes (in parenthesis) are shown (×10−6). Data are representative of three separate experiments.
Fig. 2
Fig. 2
Anti-CD3 induction of IL-15 in spleens of wild-type (h), but not of IFN-γR KO (▪) mice. IFN-γR KO and wild-type mice were challenged with anti-CD3 Ab at the indicated dose. Six hours later, total RNA was extracted from spleens (a) or thymuses (b), and real-time PCR was performed for IL-15. (a) IL-15 mRNA expression in spleens of mice. Data of one mouse at each dose are shown. The inset shows a separate experiment performed with 20 µg anti-CD3 Ab. Each bar represents the mean ± S.E. of 3 mice. *P < 0·02 in comparison with wild-type mice (Mann–Whitney U-test). (b) IL-15 mRNA expression in thymuses of three IFN-γR KO and wild-type mice that had received 40 µg anti-CD3 Ab or saline.
Fig. 3
Fig. 3
Anti-IL-15 Ab increases anti-CD3-induced apoptosis in (a) wild-type mice and (b) IL-15 protects IFN-γR KO mice from anti-CD3-induced apoptosis. (a) Two groups of wild-type mice (n = 4) were treated with anti-IL-15 Ab or control IgG. Five hours later, these mice and an additional group of 4 IFN-γR KO mice, were challenged with 20 µg anti-CD3 Ab. Forty hours post anti-CD3-challenge, apoptosis in the thymuses was measured with the use of the DNA dye PI. Each histogram represents analysis of a single thymus. Values indicate the average percentages of apoptotic cells (mean ± S.E.) for 4 mice in each group. *P < 0·05 in comparison with control IgG-treated wild-type mice (Mann–Whitney U-test). (b) Two groups of IFN-γR KO mice (n = 3) were injected with 20 µg anti-CD3-Ab and two injections of either 15 µg IL-15 in 100 µl PBS, or PBS as control, at 6 h and 18 h post anti-CD3 challenge. Wild-type mice that similarly received anti-CD3 and PBS were also included. Thymocyte apoptosis was analysed with PI. Each histogram represents analysis of a single thymus. Values indicate the average percentages of apoptotic cells (mean ± S.E.) for 3 mice in each group. *P < 0·05 in comparison with PBS-treated IFN-γR KO mice (Mann–Whitney U-test).

Similar articles

References

    1. Hirsch R, Gress RE, Pluznik DH, Eckhaus M, Bluestone JA. Effects of in vivo administration of CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol. 1989;142:737–43. - PubMed
    1. Alegre M, Vandenabeele P, Depierreux M, et al. Cytokine release syndrome induced by the 145–2C11 anti-CD3 monoclonal antibody in mice. prevention by high doses of methylprednisolone. J Immunol. 1991;146:1184–91. - PubMed
    1. Ferran C, Dy M, Sheehan K, et al. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-γ, interleukin-3 and interleukin-6 release after triggering of the CD3/T cell receptor activation pathway. Eur J Immunol. 1991;21:2349–53. - PubMed
    1. Matthys P, Froyen G, Huang S, et al. Interferon-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis: Protective role of endogenous nitric oxide. J Immunol. 1995;155:3823–9. - PubMed
    1. Shi Y, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR. In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in imature thymocytes. J Immunol. 1991;146:3340–6. - PubMed

Publication types